These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28395400)

  • 21. Risk of tuberculosis in patients treated with anti-tumor necrosis factor therapy: a nationwide study in South Korea, a country with an intermediate tuberculosis burden.
    Jung SM; Ju JH; Park MS; Kwok SK; Park KS; Kim HY; Yim HW; Park SH
    Int J Rheum Dis; 2015 Mar; 18(3):323-30. PubMed ID: 25557144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Updates on the risk factors for latent tuberculosis reactivation and their managements.
    Ai JW; Ruan QL; Liu QH; Zhang WH
    Emerg Microbes Infect; 2016 Feb; 5(2):e10. PubMed ID: 26839146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Think Globally, Act Locally: Diagnosis and Management of Latent Tuberculosis in Minnesota's Foreign-Born Population.
    Goers M; Settgast A
    Minn Med; 2015 Sep; 98(9):49-52. PubMed ID: 26442358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling.
    Houben RM; Dodd PJ
    PLoS Med; 2016 Oct; 13(10):e1002152. PubMed ID: 27780211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of tuberculosis among anti-tumor necrosis factor users in patients with a previous history of tuberculosis.
    Jo KW; Hong Y; Jung YJ; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Lee SD; Kim WS; Kim DS; Shim TS
    Respir Med; 2013 Nov; 107(11):1797-802. PubMed ID: 24029000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of latent tuberculosis in migrants to Victoria.
    Flynn MG; Brown LK
    Commun Dis Intell Q Rep; 2015 Dec; 39(4):E578-83. PubMed ID: 26779730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of an interferon-gamma release assay to screen for pediatric latent tuberculosis infection in the eastern region of the Emirate of Abu Dhabi.
    Al Mekaini LA; Al Jabri ON; Narchi H; Kamal SM; Mabrook A; Al Kuwaiti MM; Sheek-Hussein MM; Souid AK; Alsuwaidi AR
    Int J Infect Dis; 2014 Jun; 23():4-7. PubMed ID: 24657274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Latent Mycobacterium tuberculosis infection.
    Getahun H; Matteelli A; Chaisson RE; Raviglione M
    N Engl J Med; 2015 May; 372(22):2127-35. PubMed ID: 26017823
    [No Abstract]   [Full Text] [Related]  

  • 29. [Compliance with latent tuberculosis treatment: a public health challenge].
    Bishara H; Ore L; Ravell DW
    Harefuah; 2014; 153(3-4):167-70, 239, 238. PubMed ID: 24791558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric tuberculosis immigration screening in high-immigration, low-incidence countries.
    Alvarez GG; Clark M; Altpeter E; Douglas P; Jones J; Paty MC; Posey DL; Chemtob D
    Int J Tuberc Lung Dis; 2010 Dec; 14(12):1530-7. PubMed ID: 21144237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].
    Kuś J; Demkow U; Lewandowska K; Korzeniewska-Koseła M; Rabczenko D; Siemion-Szcześniak I; Białas-Chromiec B; Bychawska M; Sapigórski P; Maciejewski J
    Pneumonol Alergol Pol; 2011; 79(6):407-18. PubMed ID: 22028119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementation of latent tuberculosis screening in HIV care centres: evaluation in a low tuberculosis incidence setting.
    Wyndham-Thomas C; Schepers K; Dirix V; Mascart F; Van Vooren JP; Goffard JC
    Epidemiol Infect; 2016 Mar; 144(4):703-11. PubMed ID: 26211466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Tuberculosis screening in school health services in Geneva, Switzerland].
    Meynard A; Pfarrwaller E; Lazarevic CA
    Rev Med Suisse; 2016 Jun; 12(522):1125-8. PubMed ID: 27451510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 'either test positive' strategy for latent tuberculous infection before anti-tumour necrosis factor treatment.
    Jung YJ; Lee JY; Jo KW; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Lee KH; Lee SD; Kim WS; Kim DS; Shim TS
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):428-34. PubMed ID: 24670697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acquired latent tuberculosis infection in psoriasis patients treated with etanercept in the People's Republic of China.
    Li CR; Mao QX; Chen M; Jia WX; Yao X; Feng SY; Jia H; Gong JQ; Yang XY
    Drug Des Devel Ther; 2015; 9():5591-4. PubMed ID: 26508833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The risk of tuberculosis in Korean patients with inflammatory bowel disease receiving tumor necrosis factor-α blockers.
    Byun JM; Lee CK; Rhee SY; Kim HJ; Kim JW; Shim JJ; Jang JY
    J Korean Med Sci; 2015 Feb; 30(2):173-9. PubMed ID: 25653489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The frequency of tuberculosis chemoprophylaxis prior to TNF-α inhibitor treatment, and the incidence tuberculosis infection using a two-step screening algorithm for latent tuberculosis infection: data from the BioRx.si registry.
    Tomsic M; Rotar Z
    Ann Rheum Dis; 2012 Nov; 71(11):1909-11. PubMed ID: 22805974
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevalence and associated risk factors of latent tuberculosis infection among undergraduate and postgraduate dental students: A retrospective study.
    Lamberti M; Muoio MR; Westermann C; Nienhaus A; Arnese A; Ribeiro Sobrinho AP; Di Giuseppe G; Garzillo EM; Crispino V; Coppola N; De Rosa A
    Arch Environ Occup Health; 2017 Mar; 72(2):99-105. PubMed ID: 27018614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and implementation of a cohort review for latent tuberculosis infection.
    Aaron CL; Mancuso JD
    MSMR; 2014 Dec; 21(12):2-7; discussion 6-7. PubMed ID: 25555208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using a quality improvement approach to improve care for latent tuberculosis infection.
    Barss L; Menzies D
    Expert Rev Anti Infect Ther; 2018 Oct; 16(10):737-747. PubMed ID: 30318977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.